Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

NCT06896162 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT06896162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06896162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
June 27, 2025
Completion date
June 30, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, breast cancer, colorectal cancer, lung cancer, metastatic cancer, solid tumor malignancies